Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn’s Disease
Clinical Gastroenterology and Hepatology · 2024-11 · 22 (11) · 2271-2279.e11
DOI: 10.1016/j.cgh.2024.06.007 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-11. Verfasst von Anthony Buisson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France; Université Clermont A…. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND & AIMS: Because transmural healing (TH) could be the best therapeutic target in Crohn's disease (CD), we aimed to build and validate a score to assess TH and transmural response (TR), and to confirm their association with favorable CD outcomes. METHODS: DEVISE-CD project encompassed 2 retrospective cohorts (274 and 224 patients with CD for development and validation phase, retrospectively) and 1 multicenter prospective validation cohort (N = 46 patients). A step-by-step process was used to build the modified Clermont score (C-score). The primary end points were time to bowel damage progression, and steroid-free clinical remission with fecal calprotectin 3 mm), and enlarged lymph nodes were associated to higher risk of bowel damage progression (P 95%) and collinear (P < .0001). Bowel thickness had the highest sensitivity to change after treatment (standardized mean difference = 0.30 ± 1.0; P = .001). C-score was calculated as 0.2x(bowel thickness-3mm) + 1.5x enlarged lymph nodes + 2x ulcer. TH (C-score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France; Université Clermont Auvergne, Inserm U1071, M2iSH, USC-INRA 2018, Clermont-Ferrand, France.…
- Université Clermont Auvergne, CHU Clermont-Ferrand, DRCI, Service de Radiologie, Clermont-Ferrand, France.
- Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France.
- CHU Rennes, Univ Rennes, INSERM, CIC1414, Institut NUMECAN (Nutrition Metabolisms and Cancer), Rennes, France.
- Centre Hospitalier de la Côte Basque, Service d'Hépato-Gastro Entérologie, Bayonne, France.
- Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France; CH Thiers, Service d'Hépato-Gastro Entérologie, Thiers, France.
Zitieren
APA
Buisson, A., Junda, J., Vignette, J., Lecoq, E., Bouguen, G., Goutorbe, F., Scanzi, J., Coban, D., Dodel, M., Bazoge, M., Pereira, B., & Hordonneau, C. (2024). Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology, 22(11), 2271-2279.e11. https://doi.org/10.1016/j.cgh.2024.06.007
Vancouver
Buisson A, Junda J, Vignette J, Lecoq E, Bouguen G, Goutorbe F, et al. Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 2024;22(11):2271-2279.e11. doi:10.1016/j.cgh.2024.06.007
BibTeX
@article{Buisson2024,
author = {Buisson, Anthony and Junda, Jérémy and Vignette, Jeanne and Lecoq, Emma and Bouguen, Guillaume and Goutorbe, Felix and Scanzi, Julien and Coban, Dilek and Dodel, Marie and Bazoge, Maëva and Pereira, Bruno and Hordonneau, Constance},
title = {Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn’s Disease},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
volume = {22},
number = {11},
pages = {2271--2279.e11},
doi = {10.1016/j.cgh.2024.06.007}
}
EUVIMED